PubMed Health⌕ Search

PubMed · 11494550

[Type I IFN receptor].

Abstract

Interferon(IFN) alpha and IFN beta apparently share the same receptor structure, the type I IFN receptor, which consist of at least two subunits. The subunits are referred to as IFN AR1(IFN alpha receptor) and IFNAR2(IFN alpha/beta receptor). As IFN elicits antiviral activity by binding to receptors on the cell surface, the expression of the type I IFN receptor in liver may be directly involved in the pathogenesis of viral hepatitis and response to IFN therapy. Here we discuss if the IFN receptor expression in liver and peripheral blood mononuclear cells can be a predictive factor for the response to IFN therapy in patients with chronic hepatitis C.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Hino, Y Yamaguchi, K Okita. 2001. [Type I IFN receptor].. https://pubmed.ncbi.nlm.nih.gov/11494550/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Whole body MRI--diagnostic strategy of the future?].

Whole body magnetic resonance imaging (MRI) opens new opportunities in diagnostic radiology as systemic disease entities can be examined with high sensitivity. This can lead to a change of paradigm, so that not only organ-related but rather disease-specific MRI examination protocols can be applied which focus on the underlying pathophysiology of the disease. Whole body MRI has already been successfully used for several oncological and non-oncological indications. In addition, whole body MRI has broadened the discussion regarding its use for secondary prevention. Compared to computed tomography, MRI does not use radiation. Although whole body MRI is still in an early stage, the enormous medical and economical potential can be envisioned.

Forecasting↗